Indian vaccine innovation: the case of Shantha Biotechnics.
about
Essential medicines are more available than other medicines around the globeBiotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000.Globalization and Health: developing the journal to advance the field.High Cost Is the Primary Barrier Reported by Physicians Who Prescribe Vaccines Not Included in India's Universal Immunization Program
P2860
Indian vaccine innovation: the case of Shantha Biotechnics.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Indian vaccine innovation: the case of Shantha Biotechnics.
@ast
Indian vaccine innovation: the case of Shantha Biotechnics.
@en
type
label
Indian vaccine innovation: the case of Shantha Biotechnics.
@ast
Indian vaccine innovation: the case of Shantha Biotechnics.
@en
prefLabel
Indian vaccine innovation: the case of Shantha Biotechnics.
@ast
Indian vaccine innovation: the case of Shantha Biotechnics.
@en
P2093
P2860
P356
P1476
Indian vaccine innovation: the case of Shantha Biotechnics.
@en
P2093
Hassan Masum
Jennifer Heys
Justin Chakma
Kumar Perampaladas
Peter A Singer
P2860
P2888
P356
10.1186/1744-8603-7-9
P577
2011-04-20T00:00:00Z